EMMJAY, on iPad so only short answer as my boys are running rampant. Irinotecan for instance is an off patent drug, we simply don't need anyones permission or need to shop the oncology sector, if it works they will be lining up at the doors. ACL had a study done a little while ago that showed around 60 percent would change from Irinotecan to HA-Irinotecan upon successful trial.
I don't quite understand where you are coming from.
PoS, are you still so glad Orbis is there to keep management honest? I say that with tounge in cheek.
EMMJAY, on iPad so only short answer as my boys are running...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable